Header Logo

Connection

Michael Fill to Adrenergic beta-Antagonists

Back to Details
This is a "connection" page, showing publications Michael Fill has written about Adrenergic beta-Antagonists.
Michael Fill
Connection Strength
0.034
Adrenergic beta-Antagonists
  1. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia. Biochem J. 2016 Nov 15; 473(22):4159-4172.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.